Clearmind Medicine Inc. Current Restricted Cash And Cash Equivalents
Clearmind Medicine Inc. (CMND) had Current Restricted Cash And Cash Equivalents of $20.85 thousand as of 2026-01-31, per its 6-K filed 2026-03-12.
Financial Statements › Notes
ifrs-full:CurrentRestrictedCashAndCashEquivalents · last filed 2026-03-12
- 2023-01-31: Current Restricted Cash And Cash Equivalents 20.00K CAD.
- 2022-10-31: Current Restricted Cash And Cash Equivalents 20.00K CAD.
- 2021-10-31: Current Restricted Cash And Cash Equivalents 20.00K CAD.
CAD
| Period end | Current Restricted Cash And Cash Equivalents |
|---|---|
| 2023-01-31 | 20.00K CAD 6-K · filed 2023-03-17 |
| 2022-10-31 | 20.00K CAD 6-K · filed 2023-03-17 |
| 2021-10-31 | 20.00K CAD 20-F · filed 2023-02-06 |
USD
| Period end | Current Restricted Cash And Cash Equivalents |
|---|---|
| 2026-01-31 | $20.85K 6-K · filed 2026-03-12 |
| 2025-10-31 | $20.56K 6-K · filed 2026-03-12 |
| 2025-07-31 | $20.67K 6-K · filed 2025-09-11 |
| 2025-04-30 | $20.69K 6-K · filed 2025-06-12 |
| 2025-01-31 | $20.29K 6-K · filed 2025-03-13 |
| 2024-10-31 | $7.19K 20-F · filed 2026-01-20 |
| 2024-01-31 | $41.26K 6-K · filed 2024-03-19 |
| 2023-10-31 | $37.67K 20-F · filed 2025-01-22 |
| 2023-04-30 | $14.73K 6-K · filed 2023-06-14 |
| 2022-10-31 | $14.65K 20-F/A · filed 2024-03-18 |